WRS Therapeutics, a privately-held development-stage biotech company, is progressing a proprietary and novel platform oral drug delivery system. The company’s technology is being developed as a solution for the two unresolved, and apparently unresolvable, holy grails of drug delivery: (1) the delivery of large molecule drugs through the oral route of administration; and (2) the targeted delivery of small and large molecule drugs to specific cells, tissues and organs. The company is currently undertaking formulation optimization and pre-clinical development (in vitro and in vivo) in collaboration with a number of academic researchers at universities in Australia. It intends to raise capital in early-2017 and establish its research and development operations, and its corporate head office, in the United States.
Company Details
- Founded
- 2015
- Address
- 401 Park Avenue South, 10th Floor,united States
- Industry
- Biotechnology
- Website
- http://www.wrstherapeutics.com
- HQ
- New York, NY
Wrs Therapeutics Questions
Wrs Therapeutics's website is http://www.wrstherapeutics.com
Wrs Therapeutics's LinkedIn profile is https://www.linkedin.com/company/wrs-therapeutics
Wrs Therapeutics's industry is
Biotechnology
Wrs Therapeutics's top competitors are
Lime Therapeutics,
Mirimus,
Invitro Cell Research, Llc,
Intrommune Therapeutics,
Bluerock Therapeutics,
Legend Biotech,
Elevatebio,
Allovate Therapeutics,
Rumi Scientific,
Anterios Therapeutics.
Wrs Therapeutics's categories are Biotechnology
Wrs Therapeutics's founding year is 2015
